{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:37:25Z","timestamp":1793795845139,"version":"4.6.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ijantimicag.2007.06.012","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T08:21:05Z","timestamp":1186647665000},"page":"51-59","source":"Crossref","is-referenced-by-count":290,"special_numbering":"S1","title":["Bacteraemia in febrile neutropenic cancer patients"],"prefix":"10.1016","volume":"30","author":[{"given":"J.","family":"Klastersky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Georgala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Muanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rolston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.06.012_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1469-0691.2005.01297.x","article-title":"Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients","volume":"12","author":"Viscoli","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated with bacteremia in febrile, granulocytopenic cancer patients","volume":"30A","author":"Viscoli","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705255","article-title":"Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen","volume":"37","author":"Frere","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies","volume":"12","author":"Norgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00520-005-0898-0","article-title":"Causes of fever in cancer patients (prospective study over 477 episodes)","volume":"14","author":"Toussaint","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib7","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib9","series-title":"8th International Symposium on Febrile Neutropenia","article-title":"The duration of neutropenia","author":"Paesmans","year":"2006"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_4.13","article-title":"Science and pragmatism in the treatment and prevention of neutropenic infection","volume":"41","author":"Klastersky","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/clinids\/23.4.795","article-title":"Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis","volume":"23","author":"Cruciani","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.06.012_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/163.5.951","article-title":"Vancomycin added to empirical combination antibiotic-therapy for fever in granulocytopenic cancer patients","volume":"163","author":"Calandra","year":"1991","journal-title":"J Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T17:43:31Z","timestamp":1556732611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907002853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":12,"alternative-id":["S0924857907002853"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.06.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}